MENU
RPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Royalty Pharma (RPRX) Ownership - Who owns Royalty Pharma?

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties... Show more

Profile

Industry
Pharmaceuticals Major
Address
110 East 59th Street
Phone
+1 212 883-0200
Employees
89
Web
https://www.royaltypharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.25B
P/E Ratio
17.60
Total Cash
1.82B
Projected Growth
3.27
Total Debt
7.62B
Revenue
2.26B
Risk (Beta)
0.72
Dividend Yield
0.02
Total Cash/Share
4.20
Total Debt/Equity
N/A
Revenue/Share
3.97 USD as % of share price

Fundamentals

RPRX
Capitalization
16.2B
P/E Ratio
17.60
Risk (Beta)
0.72
Dividend Yield
0.02
Total Cash
1.82B
Total Cash/Share
4.20
Total Debt
7.62B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
3.27
Revenue/Share (as % of the share price)
3.97%
Revenue
2.26B
ROE
N/A
Book Value
6.69B
P/B Ratio
2.56
Cash Flow
N/A
Earnings
2.46
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
106K
Current Ratio
1.56
Current Revenue Per Employee
5739868.50
Dividends Per Share - Security
0.22
EBITDA
2.02B
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
6.48
Shares Held By Institutions
24.6B
Shares Outstanding - Current
432M
Total Liabilities
7.82B
Total Volume MTD
N/A
Value
1
Gain YTD
49.285
View a ticker or compare two or three
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RPRX showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of drug development services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
110 East 59th Street
Phone
+1 212 883-0200
Employees
89
Web
https://www.royaltypharma.com